Satellos Bioscience Inc.
MSCLF
$0.4284
$0.01934.72%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 38.22M | 41.19M | 48.55M | 17.34M | 20.24M |
Total Receivables | 186.00K | 338.00K | 435.10K | 141.40K | 733.60K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 280.00K | 2.84M | 1.76M | 428.60K | 372.60K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 2.43M | -- | -- | -- | 700.00 |
Total Current Assets | 41.11M | 44.37M | 50.74M | 17.91M | 21.35M |
|
|||||
Total Current Assets | 41.11M | 44.37M | 50.74M | 17.91M | 21.35M |
Net Property, Plant & Equipment | 5.00K | 3.00K | 3.50K | 12.60K | 14.60K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | 2.86M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 41.12M | 44.37M | 50.75M | 17.92M | 24.25M |
|
|||||
Total Accounts Payable | 1.06M | 1.89M | 2.06M | 1.01M | 1.16M |
Total Accrued Expenses | 1.62M | 751.00K | 1.52M | 1.67M | 1.78M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 95.00K | 63.00K | -- | -- | -- |
Total Other Current Liabilities | 95.00K | 63.00K | -- | -- | -- |
Total Current Liabilities | 2.77M | 2.70M | 3.58M | 2.68M | 2.94M |
|
|||||
Total Current Liabilities | 2.77M | 2.70M | 3.58M | 2.68M | 2.94M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.77M | 2.70M | 3.58M | 2.68M | 2.94M |
|
|||||
Common Stock & APIC | 91.29M | 86.48M | 80.66M | 51.81M | 50.71M |
Retained Earnings | -68.85M | -63.24M | -52.54M | -51.44M | -44.17M |
Treasury Stock & Other | 15.91M | 18.43M | 19.05M | 14.87M | 14.77M |
Total Common Equity | 38.35M | 41.67M | 47.16M | 15.24M | 21.31M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 38.35M | 41.67M | 47.16M | 15.24M | 21.31M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 38.35M | 41.67M | 47.16M | 15.24M | 21.31M |
|